Comprehensive analysis of copy number variations in congenital heart defects Tunisian patients: chromosomal microarray analysis insights.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khelifi Rim, Othmane Houcemeddine, Ajmi Houda, Slimani Wafa, Bennour Ayda, Dardour Leila, Soyeh Najla, Benzarti Amira, Rjiba Khouloud, Abdallah Hamza Hadj, Rassass Ahmed, Kooli Rim, Mghirbi Oussama, Kammoun Molka, Khelifa Hela Ben, Bahri Farouk, Hayet Mkaddem, Ammar Aouina, Ghanmi Sahbi, Mathlouthi Jihene, Ben Hamida Hayet, Habboul Zakia, Kemis Tarek, Kharrat Habib, Hassine Nadia, Tej Amel, Bellalah Manel, Chouikh Fatma, Houssine Mejaouel, Mahdhaoui Abdallah, Kortas Chokri, Guith Aida, Maatouk Faouzi, Naffeti Elies, Soua Habib, Gribaa Moez, Saad Ali, Mougou-Zerelli Soumaya
Аннотация
PATIENTS AND METHODS: We conducted a cytogenetic study integrating conventional karyotyping, fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA 44 K) in 20 Tunisian patients presenting syndromic CHDs and referred to our Genetics Department.
RESULTS AND DISCUSSION: CMA identified pathogenic copy number variations in four patients. These included an inherited 11 Mb deletion at 9p24.2 together with a 10 Mb duplication of 20pter; a de novo 1.2 Mb deletion at 15q26.2 with an 11 Mb duplication at 2q36.3; a de novo 113 kb deletion at 17q21.32; and a de novo 48 Mb duplication at 8q22. Several CNVs overlapped known deletion/duplication syndromes, some with previously infrequent cardiac involvement. Genotype-phenotype correlations enabled prioritization of CHD relevant genes including DOCK8, HTR2B, KANSL1, ZFPM2, and TRPS1, whose dosage sensitivity and interactions with cardiac developmental pathways may contribute to the observed phenotypes.
CONCLUSION: This study reinforces the clinical utility of CMA in detecting cryptic chromosomal abnormalities in syndromic CHD. The identified CNVs and gene candidates offer new insights into CHD genetic architecture and support CMA as a first-tier diagnostic tool. These findings highlight the contribution of rare, pathogenic CNVs in syndromic cases and suggest their integration into refined diagnostic and counseling strategies. Further functional studies are necessary to elucidate the roles of these candidates in cardiogenesis.